The price of brimonidine tartrate 0.2% can vary depending on factors such as the manufacturer, dosage form, and where it is purchased. For example, a 5 mL bottle of brimonidine tartrate ophthalmic solution 0.2% might be available for around $15 to $25.
What influences brimonidine tartrate 0.2% pricing?
Pricing for brimonidine tartrate 0.2% is affected by several elements. These include whether it is a brand-name or generic product, the specific concentration and volume of the product, and whether it is prescribed for human or veterinary use. Insurance coverage and pharmacy discounts can also lead to significant price differences.
Where can I find brimonidine tartrate 0.2% prices?
Patients and consumers can check prices at various online pharmacies and through prescription discount programs. Comparing prices across different retailers is a common strategy to find more affordable options.
How does brimonidine tartrate 0.2% work?
Brimonidine tartrate is an alpha-adrenergic agonist that works by reducing the production of aqueous humor in the eye and increasing uveoscleral outflow. This dual mechanism helps to lower intraocular pressure.
What are common uses for brimonidine tartrate 0.2%?
This ophthalmic solution is primarily prescribed to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Are there alternatives to brimonidine tartrate 0.2%?
Other medications used to manage glaucoma and ocular hypertension include prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, and miotics. Each class of medication has a different mechanism of action and potential side effects.
What is the patent status of brimonidine tartrate?
Information regarding the patent status and exclusivity of brimonidine tartrate can be found on resources like DrugPatentWatch.com [1]. Patents play a significant role in the pricing and market availability of medications, influencing when generic versions can enter the market.
Who manufactures brimonidine tartrate 0.2%?
Several pharmaceutical companies produce brimonidine tartrate 0.2% ophthalmic solution. This includes both original brand manufacturers and generic drug producers.
Sources:
[1] https://drugpatentwatch.com/